HANSA BIOPHARMA ABHANSA BIOPHARMA ABHANSA BIOPHARMA AB

HANSA BIOPHARMA AB

No trades
See on Supercharts

Price target

115.170.000.00%
The 6 analysts offering 1 year price forecasts for HNSA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to HNSA in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


HNSA EPS for the last quarter is −1.53 SEK despite the estimation of −2.42 SEK. In the next quarter EPS is expected to reach −1.98 SEK. Track more of HANSA BIOPHARMA AB financials and stay on top of what is up with the company.
In the next quarter HANSA BIOPHARMA AB revenue is expected to reach ‪70.59 M‬ SEK. Check out HANSA BIOPHARMA AB revenue and earnings and make informed decisions.
According to analysts, HNSA price target is 115.17 SEK with a max estimate of 175.00 SEK and a min estimate of 56.00 SEK. Check if this forecast comes true in a year, meanwhile watch HANSA BIOPHARMA AB stock price chart and keep track of the current situation with HNSA news and stock market news.
We've gathered opinions of 6 analysts rating HNSA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.